Olga Feld
Tel Litwinsky, TA, Israel
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Toll-like receptor 2 is overexpressed in Familial Mediterranean fever patients and is inhibited by colchicine treatment.
Journal: Best practice & research. Clinical rheumatology
Published: June 18, 2019
Efficacy and safety of long-term treatment with intravenous colchicine for familial Mediterranean fever (FMF) refractory to oral colchicine.
Journal: Rheumatology international
Published: October 06, 2018
Anakinra for Colchicine-Resistant Familial Mediterranean Fever: A Randomized, Double-Blind, Placebo-Controlled Trial.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: August 18, 2016
Normal arterial stiffness in familial Mediterranean fever. Evidence for a possible cardiovascular protective role of colchicine.
Journal: Clinical and experimental rheumatology
Published: May 13, 2016
Colchicine-free remission in familial Mediterranean fever: featuring a unique subset of the disease-a case control study.
Journal: Orphanet journal of rare diseases
Published: October 10, 2013
T helper 17 polarization in familial Mediterranean fever.
Journal: Genes and immunity
Published: March 08, 2013
Erysipelas-like erythema as the presenting feature of familial Mediterranean fever.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: January 17, 2012
Neurologic and other systemic manifestations in FMF: published and own experience.
Journal: Best practice & research. Clinical rheumatology
Published: December 04, 2011
Abnormal heart rate variability in AA amyloidosis of familial Mediterranean fever.
Journal: Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis
Published: November 15, 2011
Showing 1-10 of 10
Last Updated: 09/26/2026